Elekta to Pay humediQ EUR 8.9 Million in Legal DisputeOn May 23, 2016, an arbitration tribunal in London issued an award in a dispute between two Elekta (EKTA-B.ST) (STO:EKTAB) group companies and humediQ GmbH. The award concludes an arbitration with humediQ arising out of an agreement for the exclusive supply of Identify™ under the Elekta label, which Elekta entered into in 2011. Identify is a patient identification and setup verification product. ...
Cardiac Biomarkers - Global Strategic Business Report - Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers - Research and MarketsResearch and Markets has announced the addition of the "Cardiac Biomarkers - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. ...